The QualityStocks Daily Tuesday, September 4th, 2018

Today's Top 3 StockMarketWatch

StockMarketWatch (MNKD) +89.09%

Penny Stock Mobsters (SSOK) +67.94%

QualityStocks (PLSB) +50.00%

The QualityStocks Daily Stock List

Talon International, Inc. (TALN)

Liquid Tycoon, Penny Pick Finders, Penny Stock MoneyTrain, Penny Stock Pick Alert, Penny Stock Pick Report, PennyStockProphet, Wall Street Mover, TopPennyStockMovers, Greenbackers, Wallstreetlivechat, OtcWizard, PennyStocks24, SecretStockPromo, StockOnion, Super Nova Stock Picks, WePickPennyStocks, Winning Penny Stock Picks, and Super Hot Penny Stocks reported earlier on Talon International, Inc. (TALN), and we report on the Company today, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Talon International, Inc. is a top international supplier of zippers, apparel fasteners, trim, and stretch technology products. It supplies these products to manufacturers of fashion apparel, specialty retailers, mass merchandisers, brand licensees, as well as major retailers globally. Established in 1893, Talon is the world’s original zipper brand.

The Company has its head office in Woodland Hills, California. Moreover, it has offices and facilities across the United States, and in the United Kingdom, Hong Kong, China, Vietnam, India, Indonesia and Bangladesh.

Talon was the inventor of the zipper. It proceeded to pioneer a number of innovations customary in zippers today. Talon’s TekFit® is its newest division. TekFit® has exclusive rights to advanced fabric technologies, which facilitate the addition of mechanical stretch into most standard fabrics.

Talon develops, manufactures, and distributes custom zippers exclusively under its Talon® brand (The World's Original Zipper Since 1893). Furthermore, it designs, develops, manufactures, and distributes complete apparel trim solutions and products; and provides stretch technology for specialty waistbands, shirt collars, and other items all under its trademark and internationally renowned brands, Talon®, and TekFit®.

Last week, Talon International reported financial results for Q2 ended June 30, 2017. Revenues for the three months ended June 30, 2017 were $12.9 million. This represents a drop of $1.6 million, or 10.9 percent, versus the same period in 2016.

Talon Zipper sales were $967,000 lower than the same period in 2016. Talon Trim products, which consist mainly of sales to specialty retail branded customers, dropped by $602,000 versus the same period in 2016. Both business divisions experienced reduced sales to mass merchandising brand customers and specialty retail brands customers.

Net income for the quarter was $604,000 or $0.01 per share versus $958,000, or $0.01 per share, for the quarter ended June 30, 2016. Net income for the six months ended June 30, 2017 was $610,000. This represents a drop from $1.0 million in the same period in 2016.

Mr. Larry Dyne, Talon International's Chief Executive Officer, stated, “The soft retail, brick & mortar apparel market negatively affected our second quarter performance. While the environment may continue to be tough in the near future, we remain focused on our corporate initiatives. By leveraging existing relationships, we are building on new opportunities, both within our Zipper and Trim products.”

Talon International, Inc. (TALN), closed Tuesday's trading session at $0.065, up 16.28%, on 62,184 volume with 1 trade. The average volume for the last 60 days is 8,118 and the stock's 52-week low/high is $0.0559/$0.12.

chart

Omagine, Inc. (OMAG)

SmallCapVoice, Information Solutions Group, Agoracom, BUYINS.NET, PennyStocks24, and OnTheMar reported earlier on Omagine, Inc. (OMAG), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Omagine, Inc. conducts all its real-estate development, tourism, and entertainment business activities through either its 60 percent owned subsidiary Omagine LLC or its 100 percent owned subsidiary Journey of Light, Inc. OTCQB-listed, Omagine’s concentration is on real-estate, entertainment, and hospitality opportunities in the Middle East and North Africa (MENA Region).

Incorporated in 2004, Omagine is based in New York, New York. It has a subsidiary in Muscat, Oman. The Company’s intention is to open branch offices in Beirut, Lebanon and in Dubai, The United Arab Emirates (UAE) during 2018.

Omagine announced in October 2014 that Omagine LLC signed a Development Agreement (DA) with the Government of the Sultanate of Oman. Omagine organized Omagine LLC under the laws of Oman to design, develop, own, and operate a tourism and real-estate development project in Oman named the Omagine Project.

Omagine LLC owns the Omagine Project. The other Omagine LLC shareholders are the office of Royal Court Affairs (RCA), which owns 25 percent, and two subsidiaries of Consolidated Contractors International Company, SAL (CCIC), which jointly own 15 percent.

As well as the Omagine Project in Oman, the Company has been having discussions with Omani government officials regarding other projects in Oman. Omagine has held initial discussions with government officials and business people in the MENA region concerning comparable projects and other business opportunities there.

Omagine announced in July of 2016 that its subsidiary, Omagine LLC, signed and registered with the Government of Oman, a Usufruct Agreement (UA), which legally perfects Omagine's ownership of the development rights (the Usufruct Rights) over 245 acres of beachfront land in the Sultanate of Oman.

The Omagine Project will be a union of cultural, heritage, educational, entertainment, and residential components. This includes a high culture theme park containing seven pearl shaped buildings, associated exhibition buildings, a boardwalk, an open-air amphitheater and stage, and open space green areas.

Additionally, the Project includes commercial office buildings, shopping and retail establishments integrated with the hotels, and around 2000 residences to undergo development for sale. Moreover, it includes a canal and an enclosed harbor and marina area, associated retail shops and restaurants, entertainment venues, boat slips, and docking facilities. It also includes a five-star resort hotel, a four-star resort hotel, and conceivably a three or four-star hotel.

Currently, Omagine focuses most of its efforts on the business of Omagine LLC and particularly on the Omagine Project. The Omagine Project is a mixed-use tourism and residential real estate project. The expectation is that it will take roughly five years from the start date to complete.

Omagine, Inc. (OMAG), closed Tuesday's trading session at $0.01465, up 33.18%, on 450 volume with 1 trade. The average volume for the last 60 days is 7,439 and the stock's 52-week low/high is $0.01/$0.25.

chart

ProGreen US, Inc. (PGUS)

Amigo Bulls, Market Exclusive, Marketwired, Uptick Newswire, Investors Hangout, Insider Financial, Penny Stock Prodigy and Promotion Stock Secrets reported previously on ProGreen US, Inc. (PGUS), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

ProGreen US, Inc. engages primarily with investments in agricultural and real estate projects in Baja California, Mexico. The Company is focusing on intensifying its property investments in Baja California, Mexico, via its joint venture (JV) partnership with Inmobiliaria Contel, and through its subsidiary Procon Baja JV. ProGreen US has its corporate office in San Diego, California.

Regarding ProGreen US’s Baja Project, the Company entered into a JV with a Mexican landowner, Inmobiliaria Contel and has jointly created Pro Baja. This is its newest JV with ProGreen owning 51 percent and Inmobiliaria Contel 49 percent. ProGreen US established an office location in Ensenada. It serves as headquarters for all of its activities in Baja California.

Procon and Contel operate from this location. Contel is currently active in the high margin produce industry, growing crops for exporters to the U.S. market, with an abundance of land available for expansion under its JV partnership.

Procon has acquired 5,100 acres of land with 4.7 miles of oceanfront on the Bay of El Rosario, for which a master plan is being drawn for the development of a very large, completely green, international vacation and retirement community named "CieloMar." ProGreen US completed development of the first tract of land, which consists of approximately 300 acres. Of this, some 100 usable acres were cleared.

ProGreen US previously signed another agreement for a further 1,900 acres (500-800 usable for farming), and a 3-year option for 11,500 acres (1000-2500 usable for farming). The land, once developed and prepared, will be offered for long term lease (10-15 years), with the JV holding the title.

ProGreen US earlier started the process of obtaining the certification of its agriculture operations in Baja California, for direct export. This is so it can sell the ProGreen Farms™ produce directly to prospective U.S. buyers.

Recently, ProGreen US announced that it's subsidiary, Procon Baja JV (Procon), closed on the purchase and took possession of the new 2,500-acre tract of land in Baja California. The total purchase price is $160,000 (USD).

In July, ProGreen US announced that the Phase I Execution Plan for Cielo Mar was completed for presenting to authorities in July. The Phase I Execution Plan presentation included an overview drawing, many additional drawings, the detailed environmental impact statement, photos, videos and other information. The presentation of the plan to the authorities was a major milestone for the Cielo Mar development. Upon Approval (indicated to be September-October), the land will be changed from "rustic" to "development" land. Then, work on the infrastructure can commence within weeks.

In August, ProGreen US announced that red chili peppers from the ProGreen Farms™ operation in Baja California were now being delivered to Huy Fong Foods, Inc., maker of the original Sriracha chili sauce, in Irwindale, California. The Company's U.S. distribution subsidiary, ProGreen Farms US, LLC, imports produce from the Rancho Arenoso farm, near El Rosario, Baja California, Mexico.

ProGreen Farms™ Rancho Arenoso is growing chili peppers on the roughly 100 acres now being farmed. It has plans for diversifying the operation with other kinds of produce for U.S. buyers as it expands onto the close by 2,500 acres, which ProGreen's Mexican subsidiary, Procon Baja JV, acquired this past June.

ProGreen US, Inc. (PGUS), closed Tuesday's trading session at $0.007, down 6.67%, on 5,656,024 volume with 64 trades. The average volume for the last 60 days is 1,754,977 and the stock's 52-week low/high is $0.006/$0.0393.

chart

Two Rivers Water & Farming Company (TURV)

IRGnews Alert, 4-Traders, Marketwired, SmallCapVoice, Green Rush Review, Simply Wall St, TopPennyStockMovers, Insider Financial, Barchart, Stock News Now, Cannabis Financial Network News, Jet-Life Penny Stocks, and Stock Guru reported earlier on Two Rivers Water & Farming Company (TURV), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Two Rivers Water & Farming Company is building a new water model for the arid regions of the southwestern United States. The Company assembles its water assets through acquiring irrigated farmland with senior water rights because 85 percent of water rights in the arid southwest are owned by agricultural interests. Two Rivers transforms the value of its water rights and farmland through continually developing operations, which produce more revenues and better profit margins. Two Rivers Water & Farming has its headquarters in Denver, Colorado. GrowCo, Inc. is an indirect subsidiary of the Company (majority-owned subsidiary).

GrowCo was established in May of 2014 to build greenhouses and processing facilities for lease to licensed marijuana growers in Colorado. GrowCo, via its subsidiaries, combines proprietary greenhouse technology with the water, land, and capital to build state-of-the-art greenhouse facilities for licensed marijuana growers. GrowCo concentrates on the construction of cannabis greenhouses and providing financing and administrative services to the tenants of the greenhouses.

Two Rivers’ produce sells to national accounts by way of its wholly-owned subsidiary Dionisio Farms & Produce. Concerning Water, Two Rivers owns a portfolio of water rights in the Arkansas River Basin in Colorado, acquired in connection with its purchases of irrigated farmland.

Two Rivers Water & Farming has formed a separate company to focus on its existing and future investments in water. This new subsidiary is Water Redevelopment Company - a Delaware corporation. The Company’s first area of focus is in the Huerfano-Cucharas river basin in southeastern Colorado. Its present farm operations convert feed crop farmland into fruit and vegetable crop production in Pueblo County, Colorado.

Two Rivers provides greenhouses and processing facilities for licensed marijuana growers in Colorado on land with water rights not used for fruit and vegetable crop production. Additionally, the Company develops Metropolitan Districts to serve underserved communities in rural areas in which Two Rivers' farmland and water rights are located.

Two Rivers Water & Farming Company earlier announced that it is making significant progress on its hemp crop share arrangement and water redevelopment project. The Company stated that land development sales are progressing ahead of plan. Two Rivers' hemp crop share arrangement is with a southern Colorado hemp grower. Two Rivers’ core focus is its water assets. Therefore, work continues toward the monetization of its water assets. 

Two Rivers Water & Farming Company (TURV), closed Tuesday's trading session at $0.3199, up 0.35%, on 377,322 volume with 120 trades. The average volume for the last 60 days is 203,259 and the stock's 52-week low/high is $0.105/$0.88.

chart

Escalon Medical Corp. (ESMC)

Stock Twits, Morningstar, OTCPicks, MarketWatch, Stockhouse, Wall Street Resources, FeedBlitz, and PennyToBuck reported earlier on Escalon Medical Corp. (ESMC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Escalon Medical Corp. specializes in the development, marketing, and distribution of ophthalmic diagnostic imaging and surgical products. It is working to grow its ophthalmic business through further developing and diversifying its product offering via internal development programs, strategic partnerships, and the acquisition of technology to best take advantage of its distribution capabilities.

Escalon Medical has research and development (R&D), manufacturing, and distribution operations in New Hyde Park, New York; New Berlin, Wisconsin; and Stoneham, Massachusetts. OTCQB-listed, the Company has its head office in Wayne, Pennsylvania.

Escalon Medical markets its products by way of independent sales representatives. The Company primarily markets to teaching institutions, hospitals, and eye surgery centers.

In 2000, Escalon Medical acquired Sonomed, Inc. Since then, via acquisition, product divestitures, partnerships, and product development, the Company has grown and expanded its product offerings. Sonomed, Inc. and Escalon Medical Imaging are wholly-owned subsidiaries of Escalon Medical Corp.

Escalon Medical’s products include an assortment of ophthalmic ultrasound, digital imaging and photography, and image management systems. In addition, its products include surgical products, including intraocular gases, fiber optic light guides and sources, and other surgical vitreoretinal instruments. All of its ophthalmic products are branded as Sonomed Escalon. Moreover, Sonomed Escalon maintains certification for compliance with ISO1385 Quality Management Systems for Medical Devices.

The Sonomed Escalon group is a leader in ophthalmic diagnostics imaging. Sonomed Escalon provides ultrasound, digital photography, and image management systems. Sonomed Escalon Rx products include mydriatics/cyclopegics; diagnostic supplies; anesthetics/combo products; antibiotics, steroid combination; injectable dyes, surgical products, and office products.

Sonomed Escalon offers its Vu Pad in regard to Ophthalmic Ultrasound. This is a new class of ophthalmic ultrasound versatility. It is configurable with B-scan, A-scan, UBM or any combination. Furthermore, surgical solutions offered include vitreoretinal gases and devices. The Company’s diagnostic solutions include AXIS image management; ophthalmic ultrasound; mobile vision analysis; adaptive refractor; perimetry; digital imaging, and tonometry.

Escalon Medical Corp. (ESMC), closed Tuesday's trading session at $0.171, even for the day. The average volume for the last 60 days is 7,560 and the stock's 52-week low/high is $0.10/$0.36.

chart

Surna, Inc. (SRNA)

Hot Stock Profits, Ascending Stocks, Promotion Stock Secrets, Wall Street Mover, TopPennyStockMovers, Marketbeat, CFN Media Group, PennyStockRumors, DSR News, PricelessPennyStocks, Value Penny Stocks, Cannabis Financial Network News, SmallCapVoice, Greenbackers, PHUB News, Actual Gains, OTC Stock Review, and Market Wire Stocks reported on Surna, Inc. (SRNA), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Surna, Inc. develops, acquires, produces, and sells equipment for the legal marijuana industry. It develops innovative technologies and products to monitor, control, and address the energy and resource intensive nature of indoor cannabis cultivation. The Company’s mission is to acquire intellectual property (IP) and scalable operating companies in the nascent, legal marijuana industry with a focus on disruptive technology, equipment, as well as related support services. OTCQB-listed, Surna is based in Boulder, Colorado.

A technology business, the Company’s goal is to dominate the infrastructure, growing, and support side of the worldwide cannabis industry. The foundation of Surna’s present revenue stream is on its chief product offerings - supplying industrial technology and products to commercial indoor cannabis grow facilities.

Surna engineers, manufactures, and distributes state-of-the art equipment and systems for Controlled Environment Agriculture (CEA). Currently, the Company’s specialty is commercial indoor cannabis cultivation. Its business model excludes the production or sale of marijuana. Via its wholly-owned subsidiary, Hydro Innovations, Surna provides a complete line of commercial and small business indoor agriculture equipment.

Surna has its signature water-cooled climate control platform. It has filed a provisional patent application covering enhancements to its proprietary Climate Control Systems and Methods used in indoor gardens. The patent includes an industrial process that provides electricity, heating, and cooling while utilizing the resulting carbon-dioxide (CO2) produced as a nutrient for the plants.

Surna’s intention is to integrate this and other proprietary technology into a new, commercial-grade power-generating and environmental control system product. The system is undergoing design to provide a near zero waste energy alternative for the cannabis industry.

Regarding Services, Surna provides an array of services to help from project inception to post production maintenance. These services include consulting, engineering, bio-security, odor control, and installation support. The Company also offers its product family. These products are for climate control, automation, and biosecurity.

Surna also offers its hybrid building solution as well as parts and accessories. The design of its hybrid building is for efficiency. This is Surna’s turnkey solution that keeps one’s facility sealed while reducing energy consumption.

Surna, Inc. (SRNA), closed Tuesday's trading session at $0.1601, down 1.72%, on 308,428 volume with 115 trades. The average volume for the last 60 days is 448,195 and the stock's 52-week low/high is $0.093/$0.485.

chart

AEON Global Health Corp. (AGHC)

Amigo Bulls, Stockhouse, InvestorsHub, YCharts, TradingView, The Street, Stock Target Advisor, Stockopedia, Penny Stock Hub, Stockwatch, Simply Wall St, Zacks, Stockflare, Dividend Investor, and Investors Hangout reported earlier on AEON Global Health Corp. (AGHC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

AEON Global Health Corp., together with its subsidiaries, provides an array of clinical laboratory testing services in the U.S. It offers diagnostic services in Cancer Genomics, Toxicology, Pharmacogenomics, as well as Health Technology Applications. The Company previously went by the name Authentidate Holding Corp. It changed its name to AEON Global Health Corp. in January of this year. OTCQB-listed, AEON Global Health is based in Gainesville, Georgia.

The Company’s main business emphasis is providing a “personalized medicine” approach to laboratory testing services. This is to provide customers with actionable medical information. AEON is the fastest growing clinical lab and healthcare services organization in the U.S. It is first in healthcare technology research and development (R&D) where its proprietary methodologies provide expedited and highly accurate urine and oral fluid (saliva) test results.

AEON is an innovator in the genomic testing area. It has a wide-ranging menu of genetic tests and a pipeline of additional molecular-based tests in development. The Company provides post contract customer support services. The design of AEON’s Telehealth Solutions is to improve outcomes and decrease hospital readmission through helping clinicians closely monitor patients with chronic illnesses including CHF, COPD and Diabetes.

AEON Clinical Labs services include Cancer Genomics, Pharmacogenomics, Toxicology, and Women’s Health. Health Technologies services include Inscrybe®. This is a secure and simple interface. Inscrybe® enables physicians, nurses, hospital staff, and external care facilities or health insurers to send, receive, sign, and track healthcare records, supporting documents, patient discharge orders and referrals or lab results and images on the web or through electronic fax instead of transferring paper.

AEON Global Health has agreed with Sabal Therapeutics, LLC to be the primary laboratory marketer of Naprosyn®. This is the branded naproxen oral suspension USP. With this agreement, AEON will become the exclusive clinical laboratory marketing representative of Sabal Therapeutics. It will market the drug alongside of its industry-leading drug monitoring service.

Regarding Toxicology Testing, AEON Global Health offers accurate and quick quantitative testing of drug metabolite levels in urine and oral fluids. The Company’s testing encompasses greater than 80 analytes and metabolites. Its HPLC-tandem mass spectrometry can analyze wider molecular weight and polarity ranges of analytes, providing better selectivity and sensitivity.

AEON Global Health Corp. (AGHC), closed Tuesday's trading session at $0.67, even for the day. The average volume for the last 60 days is 4,808 and the stock's 52-week low/high is $0.40/$1.65.

chart

Artemis Therapeutics, Inc. (ATMS)

Zacks, OTC Markets, Stockhouse, InvestorsHub, NASDAQ.com, and Simply Wall St reported on Artemis Therapeutics, Inc. (ATMS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Artemis Therapeutics, Inc. concentrates on the development of new therapies for the treatment and prevention of severe and life-threatening infectious diseases. The Company’s lead product candidate is Artemisone. This is a unique, synthetic artemisinin derivative with potent anti-viral and anti-parasitic properties.  A clinical-stage biopharmaceutical company, Artemis Therapeutics is based in New York, New York. The Company lists on the OTC Markets’ OTCQB.

Artemisone is a best-in-class artemisinin. It has been studied in a Phase 2 clinical trial for the treatment of malaria (p. falciparum). Artemisinin and its derivatives, including artesunate, artemether, arteeter and dihydro-atemisinin (DHA), have for numerous years been the foundation of treatment of uncomplicated p. falciparum malaria. Phase II clinical data has shown Artemisone to be an efficacious treatment for p. falciparum malaria infection when dosed over a 2-day or 3-day course, alike to or shorter than other available malaria treatments.

At present, Artemisone is undergoing in vitro evaluation for its activity against human cytomegalovirus (CMV). This includes transplant CMV and congenital CMV. Artemis Therapeutics announced this past June that new data on its lead product candidate Artemisone shows it is a potent inhibitor of human cytomegalovirus (HCMV) replication in preclinical assays.

Artemis Therapeutics has licensed pre-clinical data from Hadasit Medical Research Services and Development Ltd. in HCMV and clinical data from Hong Kong University of Science and Technology R and D Corporation Limited (RDC) in the treatment of Malaria.

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation for Artemisone for the treatment of malaria. Artemis Therapeutics is now qualified to receive substantial benefits by way of its orphan drug development program. This includes more frequent FDA interactions, protocol assistance, and also tax credits for clinical research expenses.

Recently, Artemis Therapeutics announced that data on its lead product candidate Artemisone were published in two separate articles in the journal Antimicrobial Agents and Chemotherapy.  The studies indicate that Artemisone in a preclinical setting is a potent inhibitor of human cytomegalovirus (HCMV) replication and the transmissible stages of malaria.

Artemis Therapeutics, Inc. (ATMS), closed Tuesday's trading session at $0.85, even for the day. The average volume for the last 60 days is 707 and the stock's 52-week low/high is $0.6501/$1.70.

chart

K92 Mining, Inc. (KNTNF)

Future Money Trends, TradeKing, Investors Hangout, GuruFocus, Marketwired, Stockhouse, MarketWatch, InvestorsHub, Barchart, OTC Markets, Morningstar, and Resource Stock Digest reported earlier on K92 Mining, Inc. (KNTNF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

K92 Mining, Inc. engages in the exploration and development of mineral deposits in Papua New Guinea. It has commenced gold production from the Irumafimpa Gold Deposit that together with the Kora Gold Deposit is part of its Project located in the Eastern Highlands province of Papua New Guinea. K92 Mining is based in Vancouver, British Columbia and the Company lists on the OTC Markets Group’s OTCQX.

Kainantu highlights include existing infrastructure. This includes underground mine development, a mill processing facility, staff housing, a licensed tailings pond, office space, paved access roads, and a reliable hydro supply through a dedicated power line. The Kainantu property covers a total area of around 410km2.

In addition, Kainantu highlights include USD $41.3 million invested in exploration drilling and definition drilling. The current resource estimate is based on 78,935m of drilling through 767 drill holes.

The Process Mill previously successfully treated the first batch of underground ore delivered from Irumafimpa, with concentrate now produced. There is a major opportunity to expand known zones of mineralization, and for the discovery of new ore bodies. K92 Mining attained and declared commercial production, effective February 1, 2018, at its Kainantu Gold Mine in Papua New Guinea.

This past August, K92 Mining announced an updated resource for Kora North. The updated resource for Kora North consists of a Measured Resource of 242,900 tonnes @ 13.9 g/t Au, 19 g/t Ag and 1.0% Cu; an Indicated Resource of 442,800 tonnes @ 11.8 g/t Au, 21 g/t Ag and 1.2% Cu; and an Inferred Resource of 1,084,400 tonnes @ 13.6 g/t Au, 15 g/t Ag and 1.0% Cu. Exploration drilling began on the Yanobo/Yompassa porphyry target.

During Q2 2018, K92 Mining produced 10,485 ounces of gold, 128,634 pounds of copper and 1,671 ozs of silver or 10,800 AuEq ozs (based on a Gold price of US$1,300/oz; Silver US$16.5/oz; Copper US$2.90/lb). Furthermore, in Q2, the Company’s mining operations centered on Kora North at its Kainantu Gold Mine in Papua New Guinea. Kora remains open for expansion in every direction and strongly mineralized at the extent of all drilling.

K92 Mining, Inc. (KNTNF), closed Tuesday's trading session at $0.6237, down 1.00%, on 92,230 volume with 31 trades. The average volume for the last 60 days is 114,830 and the stock's 52-week low/high is $0.3095/$0.7945.

chart

RenovaCare, Inc. (RCAR)

Zacks, Insider Financial, and MarketWatch reported on RenovaCare, Inc. (RCAR), and today we report on the Company, here at the QualityStocks Daily Newsletter.

RenovaCare, Inc. is developing first-of-their-kind autologous (self-donated) stem cell therapies for the regeneration of human organs. Its initial product under development targets the body’s largest organ, the skin. RenovaCare is the developer of the patented CellMist™ and SkinGun™ technologies. These are for isolating and spraying a patient’s own stem cells onto burns and wounds for fast self-healing. RenovaCare has its corporate headquarters in New York, New York.

The Company’s flagship technology, the CellMist™ System, employs its patented SkinGun™ to spray a liquid suspension of a patient’s stem cells – the CellMist™ Solution – onto wounds. RenovaCare is developing its CellMist™ System as a promising new option for patients suffering from burns, chronic and acute wounds, and also scars. The CellMist™ System targets patients globally who suffer burns, chronic and acute wounds, acne scarring, and skin defects and diseases such as vitiligo.

In investigative clinical use in the U.S., SkinGun™ treatments have shown the potential to naturally and rapidly heal burns and other serious wounds. Based on preliminary case studies, CellMist™ System patients can be treated within 90 minutes of entering an emergency room. A patient’s stem cells are isolated, processed, and sprayed onto wound sites for fast healing.

RenovaCare has a partnership to validate the science behind its pioneering technology for treatments of wounds, burns, and other skin defects. Its research partner is Berlin-Brandenburg Center for Regenerative Therapies (BCRT), a translational research center at Charité - Universitätsmedizin Berlin, one of the world’s largest university hospitals.

RenovaCare announced in December of 2016 that it bolstered its patent portfolio with the issuance of a U.S. patent for its novel SkinGun™ device. The United States Patent and Trademark Office (USPTO) granted an additional 30-month extension for the patent, providing protection beyond the year 2035. The issuance of the U.S. patent reinforces the Company’s current patent protections in Germany.

Recently, RenovaCare announced that its approach to isolating a patient’s own stem cells for subsequent spray onto burns and wounds was validated by researchers in ‘Differentiation’, a foremost peer-reviewed scientific publication. According to their findings, the methodology, which has been adopted by RenovaCare, successfully isolates those specific cell populations with the greatest regenerative capacity to support the growth of fully-functioning skin.

Mr. Thomas Bold, RenovaCare’s President and Chief Executive Officer, said, “It’s very exciting to have this scientific validation that our approach is ideal for rapid and natural skin regeneration. We’ve always had confidence that our methodology isolates the body’s most regenerative cell population before spray application with our ultra-gentle SkinGun™.”

RenovaCare, Inc. (RCAR), closed Tuesday's trading session at $2.035, up 8.24%, on 35,382 volume with 109 trades. The average volume for the last 60 days is 30,326 and the stock's 52-week low/high is $1.18/$12.82.

chart

The Pulse Beverage Corporation (PLSB)

The Green Baron, PennyStocksV2, BestStocksDaily, Wall Street Resources, RedChip, Marketbeat.com, Greenbackers, Microcap MarketPlace, Wall St Insider Stocks, Ceocast News, SmallCap Network, FreeRealTime, HoleinOneStocks.net, and PennyStockClub reported earlier on The Pulse Beverage Corporation (PLSB), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

The Pulse Beverage Corporation is the maker of Natural Cabana® Lemonades, Limeades, and Coconut Waters. Pulse introduced Natural Cabana® Lemonade in 2012. Since that time, it has developed a multi-national distribution system through greater than 155 distributors in 49 U.S. States, Canada, Mexico, Panama, Bermuda, and Ireland. The Pulse Beverage Corporation is based in Northglenn, Colorado. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Pulse’s goal is to be one of the market leaders in the development and marketing of nutritional/functional beverage products that provide real health benefits to a large portion of the population and are convenient and appealing to consumers. The Company offers Natural Cabana® Lemonade/Limeade in seven, low-calorie flavors. In addition, it offers Natural Cabana® Coconut Water in pineapple and natural flavors.

Pulse Beverage’s business model uses warehouse direct and key accounts. The Company has secured more than 20,000 listings for its Lemonades and Limeades and more than 5,000 listings for its Coconut Waters with regional and national grocery and convenience chain stores.

Pulse Beverage teams up with major retailers. These retailers include Walmart, Albertsons/Safeway, Food Max, Kroger, Stater Bros, Houchens, 7-Eleven, United C-stores, Kmart, and Weis Markets. Major retailers also include King Kullen, WinCo Foods, Price Less Markets, Hy-Vee Supermarket, Gristede's Foods, Toot n Totem, and Travel America.

In September, Pulse Beverage announced that it started to ship its Natural Cabana® Coconut Waters to SunRidge Farms™ operating in Santa Cruz County, California. These products will be distributed to its Northern California Natural and Organic grocery store customers.

Additionally, in September, Pulse Beverage announced that it has been providing its Natural Cabana® Coconut Waters, Lemonades and Limeades to North American consumers by way of bulk sales to DFW Supply Company of Fort Worth, Texas. DFW operates a business to consumer (B2C) e-commerce website at www.BuyPulseDirect.com.

The Pulse Beverage Corporation (PLSB), closed Tuesday's trading session at $0.0003, up 50.00%, on 29,844,221 volume with 9 trades. The average volume for the last 60 days is 15,121,538 and the stock's 52-week low/high is $0.0001/$0.0021.

chart

China YCT International Group, Inc. (CYIG)

SquawkBoxStocks, Penny Pick Finders, TerrificPennyStocks, Breaking Bulls, AwesomeStocks, PennyStocks24, Chatter Box Stocks, MyBestStockAlerts, Buzz Stocks, PennyStockCrowd, Marquee Penny Stocks, Penny Stock Rumble, PennyStocksV2, and Planet Pennies reported earlier on China YCT International Group, Inc. (CYIG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

China YCT International Group, Inc is a developer, manufacturer, and distributor of traditional Chinese medicines (TCM). A biotechnology company, it mainly concentrates on producing medicines and selling organic healthcare products. In addition, China YCT is a significant player in the Acer Truncatum oil business. The Company anticipates that this will be a billion-dollar market in the near future. China YCT International Group has its head office in Sishui County, Shandong Province, China. It lists on the OTC Markets Group’s OTCQB.

The Company engages in developing, manufacturing, and selling its own TCM’s made primarily from ginseng extract, manufacturing and distributing acertruncatumbunge seed oils, and distributing health care supplement products in China.

China YCT International Group announced in May 2017 that it signed an agreement to purchase the Acer Truncatum business from Shandong YCT Group Co. Ltd. The expectation is that this new business will increase sales by a billion U.S. dollars for China YCT in the next 5 years.

Acer Truncatum is a kind of maple. It has 300 species around the world. Acer Truncatum is only available in China.

The Acer Truncatum oil contains 5.8 percent of nervonic acid. Acer Truncatum is contained in plants, and nervonic acid can undergo extraction from these very economically. After more than 40 years’ research and experiments, the Chinese government approved Acer Truncatum oil as general wood food oil that can be used as a general food oil, such as soybean, corn, olive, as well as other food oils.

Recently, China YCT International Group announced its financial results for the fiscal year ending March 31, 2017. The Company achieved $56,463,164 in revenue. This represents an increase of 18.1 percent or $8,636,056, versus $47,827,108 for the same period the year prior.

The Company achieved net income of $10,054,654. This represents a 19.5 percent or $1,637,885 increase, versus $8,416,769 during the fiscal year ended March 31, 2016.

Mr. Yan Tinghe, China YCT International Group's Chief Executive Officer, said, "The Company's next business goal is to become a leading enterprise in research, cultivation, and production in the domestic and international market for acertruncatum woody edible oils."

China YCT International Group, Inc. (CYIG), closed Tuesday's trading session at $0.80, up 31.15%, on 100 volume with 1 trade. The average volume for the last 60 days is 4,052 and the stock's 52-week low/high is $0.25/$1.01.

chart

Versus Systems, Inc. (VRSSF)

TradingView, Barchart, and InvestorsHub.com reported on Versus Systems, Inc. (VRSSF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Versus Systems, Inc. has developed a proprietary in-game conditional prizing and promotions engine. It enables players to compete for and win real prizes from brands that they care about while playing their favorite games. Fundamentally, the Company’s white-label platform gives players the opportunity to play for the things they love, inside of the games they love.

Versus Systems lists on the OTC Markets Group’s OTCQB. The Company is based in Vancouver, British Columbia.

Versus Systems permits game developers and publishers to provide players with prizes, which players can win inside their favorite games. This adds engagement as well as a new dimension to gameplay. Versus prizing includes gear, apparel, tickets, energy drinks, and downloadable content from brands such as Tier 1, Han Cholo, Rockstar Energy Drink, and others.

Recently, Versus Systems was named #13 on the 100 Top Companies for Millennial Women by foremost women’s platform Mogul. The Company received recognition alongside Nike, Pinterest, and Deloitte for their efforts to attract, promote, as well as empower women in the workplace.

Last month, Versus Systems announced that it has partnered with 704Games to provide in-game prizing in their upcoming titles. 704Games is working with the Company’s prizing and promotions platform to provide players with opportunities for in-game prizing and real-world rewards in their upcoming titles on mobile and console.

704Games released NASCAR Heat Mobile this past spring. This is the first authentic NASCAR racing game on mobile to feature 40 stock cars racing at the same time. In addition, 704Games recently announced the upcoming release of NASCAR Heat 2. It will be available on Xbox One, Playstation 4, and PC.

Mr. Matthew Pierce, Chief Executive Officer of Versus Systems, said: “We are thrilled to be working with 704Games to give gamers the opportunity to win real prizes from their favorite brands inside their favorite racing games. This is a fantastic partnership for us and we look forward to building Versus prizing into all of 704Games upcoming titles.”

Versus Systems, Inc. (VRSSF), closed Tuesday's trading session at $0.20, up 5.26%, on 7,400 volume with 6 trades. The average volume for the last 60 days is 20,321 and the stock's 52-week low/high is $0.1576/$0.6042.

chart

Jerrick Media Holdings, Inc. (JMDA)

CFN Media Group and MassiveStockProfits reported earlier on Jerrick Media Holdings, Inc. (JMDA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Jerrick Media Holdings, Inc. is a digital media and technology company. It centers on the development and marketing of branded digital content and e-commerce properties. The Company produces and distributes premier digital media across many platforms for manifold targeted demographics. Jerrick Media Holdings is based in Englewood, New Jersey. The Company lists on the OTC Markets’ OTCQB.

Jerrick Media’s brand portfolio is delivered through Vocal. This is its proprietary technology and content distribution platform. All verticals are supervised by the same team and ideology, focusing primarily on revenue conversion as the foundation of all published material.

Vocal is an inventive platform. Vocal is a content distribution platform and publishing hub. The Vocal platform hosts approximately 30 niche-communities. These include science fiction, poetry, music, health and wellness, and pop culture.

Vocal enables content creators to create rich user experiences. Vocal has a seamless integration between content and commerce. Vocal leverages the power of specific and dedicated audiences with a developing content creation engine. It blends thought-provoking, appealing content with SEO (Search Engine Optimized) and monetization capabilities.

Verticals on Vocal include Beat; Feast – a celebration of food; and Geeks. In addition, Verticals include Journal, which emphasizes everything work-related; and Longevity, which presents the new frontiers of health and wellness.

Jerrick Media also has its Wander and Humans verticals. Wander is a community created for travelers. Humans is about relationships and caters to those who identify as single, married, or other. Furthermore, the Company has its Blush and Cleats verticals. Blush is for all things beauty, and Cleats is for all things soccer/football.

Jerrick Media is expanding its revenue opportunities (and those of its content creators) through taking advantage of the Jerrick library of assets via partnerships with celebrity thought-leaders and influencers. This past March, Jerrick Media Holdings announced that it entered into a Memorandum of Understanding (MOU) outlining the terms of a proposed joint venture (JV) with Thinkmill, Inc. With this MOU, Jerrick Media and Thinkmill will establish Abacus, a new Delaware entity.

Abacus will retain a non-exclusive license of the Vocal technology, users, and content from Jerrick Media for a five year period. The mission of Abacus will be to develop robust solutions for content creators through further developing the Vocal platform and the established communities and content that now exists. Thinkmill is a digital development company headquartered in Sydney, Australia.

Jerrick Media Holdings, Inc. (JMDA), closed Tuesday's trading session at $0.174755, down 12.62%, on 368,719 volume with 9 trades. The average volume for the last 60 days is 19,758 and the stock's 52-week low/high is $0.1007/$0.38.

chart

The QualityStocks Company Corner

Cyberfort Software, Inc. (OTC: CYBF)

The QualityStocks Daily Newsletter would like to spotlight Cyberfort Software, Inc. (OTC: CYBF).

Cyberfort Software, Inc. (OTC: CYBF) is a cybersecurity technology company specializing in the acquisition and development of security software, content filtering, and ad blocking technology. Headquartered in San Francisco, California, Cyberfort Software is actively dealing with various cyber threats through the development of innovative protection technologies designed for mobile, personal and business tech devices across multiple platforms.

Committed to the idea that everyone – from individuals to global corporations – should be able to enjoy a digital future free of malicious attacks robbing them of privacy and security, Cyberfort is working to strengthen its portfolio of cybersecurity IPs and stay one step ahead of cyberthreats. The growing plethora of tech devices enveloping everyday life opens the door to increasing cyberattacks through a stunning array of sophisticated cyberthreats. Protecting organizations and individuals with proactive security postures and protective measures is a key component of Cyberfort’s strategy to develop cybersecurity solutions that are smart, simple and efficient.

The company’s 2016 purchase of Vivio, a provider of pioneering AI content filtering and software protection, underscores Cyberfort’s commitment to cybersecurity. Vivio, an iOS 10 ad blocking app, currently serves over 10,000 unique users across iPhone, iPad and Mac. Vivio makes web browsing better, faster and more satisfying by blocking ads and reducing data usage, which also helps save battery life. Continuous ad blocking rule updates are delivered via an Intellectual Property Cloud-based autonomous engine with ad blocking tracker and malware detection filters.

Cyberfort recently signed a letter of intent to acquire Just Content Software which includes the Just Content app, software and underlying source code. Just Content is an efficacious and multi-functional ad blocking app that safeguards families and businesses with proprietary “Home Safe Filter” and “Business Filter” products. The Just Content app is available on iTunes and protects against unsafe links, adult content, phishing sites and inflammatory hate speech found on the internet, among other potential backdoor attacks and cyberthreats. A due diligence review is underway and a final determination regarding this acquisition is anticipated within weeks.

“Cyberfort aims to become a leader in developing cutting edge ad-blocking protective software that keeps the internet safe for families and business, which in our highly technological and immediate information-access society is a significant concern. Acquiring Just Content furthers our commitment to provide the best and most effective ad-blocking software in the marketplace,” says Cyberfort CEO Daniel Cattlin.

Favorable government regulations promoting tightened web security is a major factor driving adoption of web content filtering solution along with the public’s growing desire to better manage network bandwidth consumption and protect their online security and privacy. Cyberfort’s objective is to protect the data and integrity of personal and business computing assets and defend those assets against any threat or attack. The company’s software also offers symbiotic ad-blocking capabilities to complement its cyber defense effectiveness.

As Cyberfort continues to innovate, the Vivio team intends to leverage the current user base as a sandbox to test and optimize future incremental developments targeting an enterprise suite of tools that can be integrated into sector specific areas of growth. Key areas of focus include mobile device management, bring your own device (“BYOD”), mobile app management and secure mobile browser.

The Cyberfort leadership team is headlined by Cattlin, who offers a new age perspective to the business with expertise in project and asset management and a background in corporate finance. Cattlin brings both the operational and financial understanding to take companies from start-up and early development to expansion and capital growth within a public environment.

Chief Technology Officer Tomas Mistrik helped his team deliver a variety of technological products including the Vivio ad-blocking app for iOS 10 and the Silicon Valley-based Synergykit platform for mobile developers.

Technology Development Manager Krishna Kumar brings more than 10 years of experience in the Information Technology industry where he provided powerful security and ad-blocking measures for companies such as CSC and PayPal India.

Senior Advisor Harish Doddala brings nine years of product management and software engineering experience, delivering results for Cisco, VMware, Oracle, IBM and Siemens.

Cyberfort Software, Inc. (OTC: CYBF), closed the day's trading session at $0.06, off by 3.23%, on 24,760 volume with 4 trades. The average volume for the last 60 days is 35,748 and the stock's 52-week low/high is $0.051/$69.00.

Recent News

chart

Koios Beverage Corp. (CSE: KBEV)

The QualityStocks Daily Newsletter would like to spotlight Koios Beverage Corp. (CSE: KBEV).

Koios Beverage Corp. (CSE: KBEV) (OTC: SNOVF) (the "Company" or "Koios") is pleased to announce it will be launching two additional products in October to augment its existing line of beverages. The first product slated for release in October is a beverage infused with cannabidiol (CBD), a cannabinoid derived from hemp plants, along with Koios' proprietary nootropic stack.

Koios Beverage Corp. (CSE: KBEV) develops and distributes nature-based products that boost brain function, enhance health, and improve productivity. Its core vision is to help a billion people worldwide live more productively through the development of nootropics, which are supplements that improve cognitive abilities.

The company’s flagship product, Koios, is a GMP-certified dietary supplement. Made from natural ingredients and backed by science, Koios is designed to improve focus, memory, mental drive, clarity and energy. The company produces Koios in the following formulations:

  • Powder supplements containing nootropics as well as caffeine and lion’s mane and chaga mushrooms;
  • Vegan-friendly capsules;
  • Canned beverages containing nootropics along with MCT oil to burn fat and increase metabolism.

Not to be mistaken with prescription-only drugs which are at times used for similar effects, nootropics are over-the-counter dietary supplements; some of which, like Koios, contain ingredients that are currently used in the treatment of patients with Alzheimer’s disease. The global field of nootropics is growing rapidly and expected to reach USD $6,059.4 Mn by 2024 with a CAGR of 17.9 percent from 2016 to 2024.

According to media reports, there is believed to be significant and growing use of nootropics among high-achieving students and professionals. The UK’s leading Guardian newspaper found that nootropics are commonly used in Silicon Valley by computer industry professionals who want to “hack” their minds and maximize their productivity without any possible negative effects on the brain.

Koios was born out of the personal struggles of its founder and CEO, Chris Miller, who has ADHD. Miller found that the symptoms of his condition held him back when navigating the competitive modern workplace. Unhappy with the effects of the Adderall he was prescribed, Chris began a search for a natural remedy that would improve his attention and mental capacity.

Speaking of his struggles at this time, Miller says, “Coffee and energy drinks were no longer helping me. Eventually, I was drinking so much caffeine that I was beginning to notice negative and troubling health effects.” He adds, “I believed there had to be a better way. Better technology that the earth was providing that I could implement and not only boost my daily performance but take care of my brain and body long-term.” After years of experiments and with the help of leading scientists, he developed Koios, named after the Greek Titan who represented rational intelligence.

Koios contains the following ingredients, among others:

  • Vitamin B12: Crucial for the function of the nervous system and the synthesis of DNA, B12 also helps in the creation of red blood cells.
  • Vitamin B6: This vitamin is crucial for brain development among children and brain function in adults. B6 is also important in the production of key hormones: serotonin, which regulates mood, norepinephrine, which helps us handle stress, and dopamine.
  • Huperzine A: Developed from the Chinese club moss plant, huperzine A is used on Alzheimer’s patients to boost their memories. It is also used to raise energy levels and alertness and is the subject of medical trials to test its efficacy when combined with other drugs.
  • Bacopa: Also known as brahmi, bacopa is an Indian herb used in Ayurvedic medicine to improve concentration and memory. Modern science has recognized its effectiveness, and it is used to treat symptoms caused by Alzheimer’s disease, ADHD and anxiety.
  • Ciwujia: Sports scientists have been interested in this herb since they heard of how mountain climbers in Tibet use it to boost their performance at high altitudes. Peer-reviewed research has shown that Ciwujia has clear positive effects on endurance.

A full breakdown of Koios’ active ingredients is available on the company website.

Additionally, safety is paramount for Koios, with all its products developed in a high-grade nutraceutical laboratory which is GMP-certified and in compliance with FDA guidelines. Koios only uses high-quality ingredients sourced from the best possible locations in order to deliver a product that is not only safe but also “one of the world’s greatest nootropic blends.”

The company’s products can be found online and in stores, both across the United States and internationally, via a continuously growing distribution network.

Koios CEO Chris Miller is supported by a team with strong credentials in medical supplement start-ups, corporate finance and sales, which includes CFO/Director Anthony Jackson, Director Scott Walters, Director Konstantine Lichtenwald and Vice President of Sales Gina Burrus.

With people seeking a mental edge and cognitive boost, Koios believes that there is an opening in the market for its nature-based, over-the-counter nootropics, especially when current prescription medicines have worrying side effects..

Koios Beverage Corp. (KBEV), closed the day's trading session at $0.35, up 75.00%, on 2,930,000 volume. The average volume for the last 60 days is 30,050 and the stock's 52-week low/high is $0.001/$0.5121.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (US:TGODF) announces it has agreed with Aurora Cannabis Inc. (“Aurora”) (TSX:ACB) to extend Aurora’s exercise deadline of its first milestone option (the “Milestone Option”) under the TGOD Aurora Investor Rights Agreement by 6 weeks to October 12, 2018.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $5.3937, up 24.31%, on 3,259,739 volume with 5,811 trades. The average volume for the last 60 days is 201,330 and the stock's 52-week low/high is $2.784/$7.565.

Recent News

chart

VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQB: VVCIF)

The QualityStocks Daily Newsletter would like to spotlight VIVO Cannabis Inc. (VVCIF).

VIVO Cannabis Inc. (TSX-V: VIVO, OTCQB: VVCIF) (formerly ABcann Global Corporation) is pleased to announce that it has closed its previously announced acquisition of 100% of the issued and outstanding shares of Canna Farms Limited (“Canna Farms”) (the “Transaction”).

VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQB: VVCIF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.

“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.

VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.

VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.

This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.

VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.

VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.

Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.

VIVO Cannabis Inc. (VVCIF), closed the day's trading session at $1.4253, up 7.98%, on 763,112 volume with 674 trades. The average volume for the last 60 days is 93,391 and the stock's 52-week low/high is $1.04/$1.41.

Recent News

chart

Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF)

The QualityStocks Daily Newsletter would like to spotlight Phivida Holdings Inc. (PHVAF).

Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) is a premium functional food and beverage business based in Vancouver, British Columbia. The company infuses all of its products with organic cannabinoids from hemp, and it offers premium beverages and clinical products for everyday health.

Headquartered in Vancouver, Canada, with operations offices in southern California, Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) is a premium food and beverage company that develops CBD-infused functional foods, beverages and supplements poised for global distribution. All products in the Phivida label are infused with organic, hemp-derived cannabinoids into a variety of premium foods, beverages and clinical products for everyday health. Phivida is guided by a team of Fortune 500-caliber executives focused on a new strategic portfolio of products and brands, comprehensive consumer research, new product and brand development, improved visual identity and packaging design, and a strong distribution strategy.

The company’s motto – “Celebrating Health and Wellness, in Harmony™” – underscores Phivida’s mission to lead the alternative health care sector as the benchmark standard in premium CBD-infused functional beverages and tinctures. To execute this goal, Phivida is taking advantage of positive legislative developments in the United States and has defined an elevated national route-to-market strategy across the U.S. where small regional distributors will be now be replaced with large national distributors.

Management

Phivida’s management team includes president and CEO Jim Bailey, former president of Red Bull Canada and global chief marketing officer for Merrell Outdoors; Chief Marketing Officer Michael Cornwell, former chief marketing officer for Samsung New Zealand and the former director of marketing for Red Bull Canada; and Doug Campbell, former director of sales for Red Bull North America, who as Phivida’s chief commercial officer is tasked with driving new sales revenue growth.

Publicly traded on the Canadian Securities Exchange (CSE.VIDA) and recently graduated to the OTCQX Best Market in the USA (OTCQX.PHVAF), the company’s strong balance sheet carries CAD$15.7 million with no debt or loans with less than 60 million shares outstanding and the company is now well-capitalized to fun major mainstream distribution with a solid structure poised for long-term growth.

The Science

Using encapsulation technology, Phivida uses full spectrum CBD-hemp oil (rich in naturally occurring phytocannabinoids) converted into a water-soluble delivery format, which enhances delivery and absorption of the cannabinoids into the human body – up to an estimated tenfold.

Encapsulated CBD is infused into functional beverages, food and supplements containing a proprietary blend of phytonutraceuticals studied to target a range of health and wellness conditions. Phivida tests every product for microbials, heavy metals, pesticides, residual solvents, terpenes, and potency to guarantee less than 0.3 percent THC (tetrahydrocannabinol, the chemical compound in cannabis responsible for a euphoric high) is present.

Regulations

Federally legal under the 2014 Farm Bill, CBD from Hemp Oil is a rapid growth market across the USA. When derived from marijuana, CBD remains a schedule one controlled substances, giving hemp derived CBD oil infused products a competitive advantage on regulations. On June 28, 2018, the U.S. Senate passed the Agriculture Improvement Act of 2018 (i.e. the “Farm Bill), lifting the USA Industrial Hemp laws to an agricultural commodity status and effectively removed hemp from the controlled substance list.

Earlier this year, another milestone court ruling also provided significant regulatory support for the US CBD-Hemp sector. In February 2018, the Supreme Court preceded over the HIA (Hemp Industry Association) vs. DEA (Drug Enforcement Agency) in a class-action suit concerning the issue of CBD extracted from hemp, and the legality of industrial hemp. In the final ruling the Supreme Court unequivocally determined that – when produced domestically under the Farm Bill – hemp (and its derivatives) are not a controlled substance.

The Supreme Court ruling also found the Farm Bill (as it relates to hemp) “pre-empts” the Controlled Substances Act. Congress has since exempted Farm Bill hemp from the Controlled Substances Act (CSA) giving the Farm Bill primary jurisdiction over the governance of the CBD-Hemp Oil industry in the USA.

The DEA further conceded it does not “seek to control cannabinoids,” and that only marijuana derived cannabinoids are governed under the Controlled Substances Act. In May of 2018, the DEA issued a formal directive to all federal agencies (e.g. US Customs and Border Patrol) stating that cannabinoids are not controlled substances unless derived from marijuana, and that the “mere presence of cannabinoids” in any product or derivative does not render it a controlled substance. The Supreme Court ruling also resulted in the mediation of a settlement in what is now the third successful HIA vs. DEA suit in over a decade.

In Canada, the Senate approval of Bill C-45 legalized the production, distribution and use of recreation cannabis – with edibles to be added in 2019. The bill will officially become law as of October 17, 2018, creating a legal framework for the production, distribution, sale and possession of cannabis across Canada including cannabinoid-infused beverages.

3 Wholly Owned Subsidiaries

  • Phivida Organics Inc. offers professional-grade, wholesale, whole plant hemp oil extracts made from 100-percent certified organic hemp stalk. Phivida’s hemp oil extracts are CO2-extracted under quality assurance/clinical standards and are third-party lab tested to assure only pharmaceutical grade, cGMP certified, full-spectrum products are produced and available for sale. Phivida Organics produces hemp oil extracts that deliver nano-encapsulated cannabinoids in water soluble formulations designed to be absorbed up to 10 times faster than other oils, providing up to 400 percent bioavailability. Phivida Hemp Oil Vida+ extract products are available now online at www.Phivida.com.
  • Phivida Nutrition blends the best of nature into CBD-infused lifestyle branded beverages including a variety of CBD infused iced teas and CBD infused flavored waters.
  • Phivida Enhanced – Under the VIDA brand, CBD-infused tinctures, capsules and other supplement products are distributed to alternative health care clinics across the USA.

WeedMD-Phivida

Phivida has signed a binding letter of intent to joint venture WeedMD Inc. (TSX-V: WMD) (OTC:WDDMF) (FSE:4WE), a Health Canada federally licensed producer and distributor of medical cannabis, to form a joint venture focused on cannabis-infused beverages. The new joint-venture company, Cannabis Beverages Inc. (“CanBev”), plans to develop a production facility at WeedMD’s state-of-the-art greenhouse facility in Strathroy, Ontario, Canada. CanBev is on track to build and operate the first cannabis-infused beverage production facilities in Canada. The joint venture will focus on manufacturing, marketing and distribution of cannabinoid-infused beverages for the legalized medical and adult-use cannabis markets.

Management from both WeedMD and Phivida are collaborating on design and engineering strategies and site evaluations on a 610,000-square-foot, state-of-the art facility in Strathroy for the development of CanBev. As an emerging certified food grade production plant, the Strathroy facility is an ideal location and comes is equipped with extensive production infrastructure, including 50,000 sq. ft. of food production and packaging area, cold storage, loading docks, and adequate space to expand for future growth.

Strategic Agreements

Phivida Organics has also entered into an agreement to carry out a pharmacokinetic (PK) study on its hemp-derived, nanoencapsulated CBD with Artelo Biosciences Inc. at the University of Nottingham, School of Medicine at the Royal Derby Hospital, England. The study will test encapsulated-CBD on healthy volunteers and measure how fast and how much CBD enters the blood stream after oral consumption with each of the different formulations developed by Phivida Organics.

Phivida has also activated distribution agreements with Asayake Inc. to become one of the first federally approved CBD-infused food and supplement brands in Japan. With first mover status achieved, Phivida now markets to an underserved, yet highly informed population of 127 million patients and practitioners. The supplement market in Japan is estimated at US$10 billion with the overall functional foods market at US$21 billion. The Asia-Pacific region is the fastest growing market for natural plant-based supplements. Phivida now plans to prepare a formal application to Japan’s Consumer Affairs Agency to register the company’s CBD-infused functional food and beverage products for approval under the country’s Food with Functional Claims regime. The functional beverage market in Japan is estimated at US$10.35 billion with a CAGR of 2.5 percent (2015-2025).

Further Information

www.Phivida.com
+1 (844) 744-6646 (ext. #2)
IR@Phivida.com

Phivida Holdings Inc. (PHVAF), closed the day's trading session at $0.75671, up 3.66%, on 224,253 volume with 105 trades. The average volume for the last 60 days is 41,592 and the stock's 52-week low/high is $0.05/$1.80.

Recent News

chart

Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF)

The QualityStocks Daily Newsletter would like to spotlight Marifil Mines Ltd. (MFMLF).

As Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF) moves into position to take its role in the global supply chain, a key mining industry publication has reported that electric vehicle manufacturers remain anxious to secure supplies of cobalt and lithium (http://nnw.fm/19snB). Mining Technology says that China is maneuvering to secure a tighter grip on cobalt supplies, which, along with lithium, are crucial to the production of electric vehicle power supplies.

Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF), headquartered in Vancouver, Canada, is engaged in the exploration, evaluation and acquisition of mineral rich resource properties in Argentina. A rising global demand for cobalt and lithium is generating interest in Marifil Mines and its resources located within South America’s famed “Lithium Triangle,” which include 15,267 hectares spanning its recently acquired Ratones and Fraile claims, as well as two lithium properties covering the southern portions of the Carachi Pampa salar in the Argentine province of Catamarca.

The company’s property also includes the Las Aguilas nickel-copper-cobalt deposit property, with more than four contiguous claims in the San Luis province of Argentina. The Las Aguilas property, which is 100% owned by Marifil, is noted as one of the largest cobalt properties in Argentina. Other noteworthy properties in the company’s portfolio include the Toruel copper-silver property, with more than two contiguous claims, and additional potash properties in Punta Colorada, Pedernal and El Carmen.

Marifil’s sizable portfolio of cobalt and lithium claims in what is recognized as the world’s most prolific mining jurisdiction for these resources strategically positions the company to benefit as global initiatives push demand for lithium-ion batteries toward a frenzy. Zion Market Research, a leading research and consulting firm, has forecast that the lithium-ion battery market could hit $67 billion by 2022, realizing a CAGR of more than 13.7% from 2017-2022. Both lithium and cobalt are major components of these energy storage solutions, with industry data indicating that the battery industry currently consumes roughly 42 percent of global cobalt production.

The company is reviving a lithium exploration program that was active in Argentina a decade ago, building on an unexplored mine it owns there. Marifil will utilize a large proprietary geologic and geochemical data base it developed during its 2009 lithium exploration program in the Salta and Catamarca province sites to resume lithium exploration in the region.

Applications for a second mine and negotiations to purchase a third property are underway, which would establish a significant property portfolio of ‘salar’ brine evaporation lakes. Hydrothermal solutions emanating from regional faults in area volcanoes often enrich the brine with lithium, boron, potassium and magnesium.

In addition to nearly 152,000 acres of lithium-staked properties, Marifil owns 887 acres of land for cobalt exploration and 91,565 acres of gold mining rights in an advanced exploration stage in San Roque that company engineers indicate has high gold discovery potential with “excellent infrastructure and mining friendly politics.”

To date, more than $7.5 million has been invested assessing Marifil’s flagship San Roque gold property, including nearly 16,000 meters of diamond core drilling. The property is jointly owned by Marifil and Novagold Resources, with Marifil holding a 51% stake and serving as the current project operator. The company recently commenced a drilling campaign to further evaluate several deposits of significant gold-silver-indium-lead-zinc mineralization on a 4-kilometer-long zone.

Marifil has closed a private placement funding for $2 million that will inject additional life into the company. Proceeds from the funding will benefit acquisition plans, the ongoing drilling program at Marifil’s gold claim and other output from its general working capital accounts.

Robert Abenante, a chartered professional account, serves as president and chief executive officer of the company. He has extensive experience in the public markets and has served as an officer and director of several public and private companies across various industries, with particular success in the mining sector.

Marifil Mines Ltd. (MFMLF), closed the day's trading session at $0.1263, up 4.64%, on 37,897 volume with 14 trades. The average volume for the last 60 days is 16,670 and the stock's 52-week low/high is $0.01/$0.165.

Recent News

chart

Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF).

Petroteq Energy Inc. (TSXV: PQE) (OTC: PQEFF) (FSE: A2DYWC), a fully integrated oil and gas company, announced today that it will be presenting at the 20th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The conference is being held on September 4-6, 2018 at the St. Regis New York Hotel in New York City.

Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil and gas exploration and production on mineral leases it owns in Texas with Accord GR Energy Inc. and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.

Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ, the Company’s collaboration formed with First Bitcoin Capital Corp. (OTC: BITCF). PetroBLOQ’s novel blockchain-based oil and gas supply chain management platform is currently being co-developed by the two companies.

PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.

“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy CEO Alex Blyumkin.

In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry. “API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.

Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.

The Company’s Asphalt Ridge mineral lease on 3,000-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Liquid Extraction System.

The company’s Texas location includes an ownership interest (46%) in 7,000 acres under mineral leases with Accord, a Houston-based oil and gas exploration company that focuses on the development and recovery of heavy oil reserves and deposits. Two enhanced, licensed oil recovery technologies designed to increase oil recovery from more than 80 shallow oil wells on the property are expected to substantially improve the recovery rates of heavy oil deposits in this area. In both the Utah oil sands and traditional oil patch Texas project, the Company, its subsidiaries and Accord are using proprietary technologies, processes and methodologies to recover heavy oil, providing a distinct, strategic economic advantage for Petroteq Energy and its shareholders.

The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.

The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.

Petroteq Energy Inc. (PQEFF), closed the day's trading session at $1.18, up 2.61%, on 162,492 volume with 179 trades. The average volume for the last 60 days is 386,559 and the stock's 52-week low/high is $0.29/$1.8892.

Recent News

chart

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)

The QualityStocks Daily Newsletter would like to spotlight PreveCeutical Medical Inc. (PRVCF).

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that, during its soluble gel ("Sol-gel") drug delivery research and development program (the "Sol-gel Program"), it has successfully optimised the conditions for extracting cannabinoids from one of its cannabis strains and developed a proprietary method for the accurate and precise quantification of cannabinoids present in the extract (the "Extraction Protocol").

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H), headquartered in Vancouver, British Columbia, Canada, is a health sciences company dedicated to researching and developing innovative options for preventive and curative therapies utilizing organic and Nature Identical™ products. The company is strategically staking out select positions in the medically acute areas of diabetes and obesity, pain management, neurological disorders and cancer.

PreveCeutical Medical Inc. had its beginnings in 2009 when Stephen Van Deventer, a seasoned businessman and venture capitalist, and Kimberly Van Deventer, a successful entrepreneur, met and formed a business partnership. The duo created Cornerstone Global Partners, a venture capital and business development company, and became involved in numerous ventures including building companies such as Aurora Cannabis Inc. Taking their interest in the health and wellness market further, the pair began researching how nature and science can work together to benefit health-conscious consumers. Coining and trademarking the word “PreveCeutical” – a combination of the words “preventive” and “pharmaceutical” – was a precursor to the company’s formation and incorporation in October 2015.

The company’s first product was developed in the Dominican Republic and is now marketed and distributed worldwide by PreveCeutical. It is a Caribbean Blue Scorpion venom product sold under the trade name CELLB9®. This product is an oral dilute solution infused with select peptides sourced exclusively from the blue scorpion (Rhopalurus princeps) found only in Caribbean nations. The active potentiated ingredients in CELLB9, which have been used in over 40 countries for over a decade, appear to support health at a deep, cellular level. PreveCeutical’s research team is using proprietary chemistry to generate Nature Identical™ peptides derived from natural compounds found in Caribbean Blue Scorpion venom with the goal of eventually treating, regulating and preventing cancer progression. Peptides are also being used to target an array of disease indications including metabolic disorders, pain management, cancers, cardiovascular and infectious diseases.

PreveCeutical is developing the first nose-to-brain delivery system of cannabinoids (CBDs) with a novel process that prepares insoluble drug-containing nano-micelles and successfully incorporating them into a proprietary sol-gels application, essentially creating a targeted drug delivery vehicle. Intended for use via a nasal spray, this unique formulation rapidly gels upon contact with mucosal tissue, which paves the way for direct nose-to-brain delivery. This novel application eliminates first pass metabolism (stomach, intestines, liver), potentially improving bioavailability and delivering extended time release formulations that may alleviate side effects of higher dosage therapeutics. This CBD-based patented formula is projected to be deployed in selected markets with licensed medical marijuana companies within 18 months.

PreveCeutical is working with four leading Australian research centers to develop a curative therapy for diabetes and obesity. This four-year program involves engineering a novel approach that selectively targets the gene that encodes for the protein PTP-1B, which is implicated and over-expressed in both type-2 diabetes and obesity. PreveCeutical’s gene-silencing technology would effectively “turn off” the genetic signal which leads to the over-production of this key protein molecule, bringing it back down to safe, normalized levels, and prevent the body from storing excessive fat. Diabetes kills one person every six seconds, with more than $800 billion spent globally on the disease.

Another exciting joint venture, established with Sports 1 Marketing, will focus on the therapeutic potential in the peptides and proteins connected to the Caribbean Blue Scorpion venom to potentially treat mild brain injury concussions. Developing a therapeutic product geared towards athletes who suffer from concussions could help alleviate suffering experienced by those who are affected by head trauma.

PreveCeutical Medical’s science and research team is led by Dr. Harendra (Harry) Parekh, Ph.D., who is based at the University of Queensland’s (UQ) Pharmacy Australia Centre of Excellence (PACE), and Dr. Makarand Jawadekar, Ph.D., whose 28 years of R&D experience with Pfizer Inc., is applicable in his role as chief science officer. Research collaborators include Dr. Rakesh Veedu, an emerging expert internationally in the field of molecular medicine, and Professor Grant Ramm, who is currently head of a leading medical research institute located in Brisbane, Australia.

PreveCeutical Medical is partnering with leading industry experts and companies in its quest to be a leader in the preventive health sciences sector. Its Research and Development partnership with UniQuest, the main commercialization company for the University of Queensland, provides PreveCeutical with the rights to all intellectual property arising from projects created under the agreement. PreveCeutical Medical Inc.’s management team brings an extensive portfolio of research experience, product development, deep corporate strategy and capital markets leadership to the company’s core.

PreveCeutical Medical Inc. (PRVCF), closed the day's trading session at $0.02758, off by 5.81%, on 363,218 volume with 63 trades. The average volume for the last 60 days is 653,732 and the stock's 52-week low/high is $0.002/$0.20.

Recent News

chart

Marijuana Company of America Inc. (OTC: MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

CannabisNewsAudio announces the Audio Press Release (APR) titled “Canada Leads the Way as North America Embraces a Diverse Cannabis and Hemp Industry,” featuring Marijuana Company of America Inc. (OTC: MCOA). To hear the CannabisNewsAudio version, visit: http://cnw.fm/UUiu0. To view the full editorial, visit: http://cnw.fm/1nKjO.

Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.0346, off by 0.29%, on 9,071,218 volume with 427 trades. The average volume for the last 60 days is 7,728,130 and the stock's 52-week low/high is $0.022/$0.0728.

Recent News

chart

Accelerated Technologies Holding Corp. (OTC: ATHC)

The QualityStocks Daily Newsletter would like to spotlight Accelerated Technologies Holding Corp. (ATHC).

Accelerated Technologies Holding’s (OTC: ATHC) managing director, Alex Lemberg, recently spoke to NetworkNewsAudio’s Stuart Smith about the company’s launch of Intelagy. To view the full article, visit: http://nnw.fm/7uUTW.

Accelerated Technologies Holding Corp. (OTC: ATHC) is a full-service end-to-end business solution and technology company that specializes in cloud-based disruptive technologies. The Company provides consulting and enterprise-level technology services and is developing its own disruptive technology products in the sectors of artificial social realities, short-term alternative funding platforms, electronic payment solutions, and blockchain technologies focused on social engagement, sports, entertainment and content creation.

ATHC is more than a publicly traded company determined to make a buck. Its mission is to create a pioneering business model by taking a leadership position in institutionalizing investment in the regional venture capital market. ATHC’s core values, beliefs and fundamentals revolve around today’s great visionaries – the great leaders of tomorrow. For young entrepreneurs, ATHC offers funding assistance, guidance and investment capital in return for reasonable equity, commitment and an unparalleled work ethic. ATHC and its economies of scale enable the Company to develop technology at reasonable costs while leveraging expertise and contacts for effective execution. The Company intends to create shareholder value by monetizing equity retained by ATHC.

ATHC’s investment domain and expertise lies in consumer Internet, cloud computing and software-as-a-service (Saas), mobile software and services, software-powered consumer electronics, infrastructure and applications software, networking, storage, databases and other backend systems. ATHC’s portfolio to date includes:

  • Intelagy – a wholly owned subsidiary of Accelerated Technologies Holding Group, is all about bringing business to businesses. Intelagy provides services that every business’ needs in today’s dynamic and digital marketplace. These services include discounted Merchant Services, Merchant Cash Advances (working capital and loans for businesses), Mobile Processing, Web Design and Hosting solutions, Printing, Local Marketing, Online Marketing, Reputation Management, Prepaid Debit Card Solutions, Payroll Services, and Telecom needs for small, mid-sized and enterprise-level businesses.
  • Finbridge Holdings provides capital to alternative lenders with receivables between $2 million and $5 million and to those operating in merchant cash advance and other short-term micro loan environments. Finbridge Holdings’ lending model provides ISOs with an alternative to private placement capital to obtain cash to grow their business. Finbridge intends to be a leader in the loans-to-lender space, primarily focused on those specializing in the small to medium business lending channel.
  • XStreamCorp – a Reality Gaming Social Network. XStreamCorp presents an opportunity to penetrate popular social gaming networks by incorporating proprietary technologies that provide users with streaming video, audio and messaging capabilities. These enhancements will dramatically change the player experience in online gaming. Revenue is expected via sales of in-game virtual goods in Social Poker Play formats and events; in-game advertising; and banner advertising around the Company’s gaming portal.
  • IconXchange will endeavor to provide a decentralized, open, resilient infrastructure for a new generation of human funding that includes blockchain-based IconXchange Coins and value-based IXC tokens. IconXchange aims to be a platform through which valuable brands are identified, grown, and incentivized. A value-based token enables enhanced liquidity and accelerated funding. IconXchange intends to capitalize on the blockchain’s evolution and improvement without being locked into any one protocol or platform.

ATHC is the destination to discover professionals, guidance, cross marketing opportunities, industry trends, and investments. The Company was built with a unique and scalable approach to collect, leverage and contribute to a strong community of venture capital partners, dynamic sales and marketing verticals, and in-house data teams armed with powerful machine learning, data science, development, management and execution skills. ATHC provides corporate consulting for private and publicly traded companies; technology planning and engineering services; installation and maintenance of cybersecurity resources; and venture capital and financing.

The management team at ATHC is driven, committed, and experienced in building infrastructure for startups. President Kevin H. Kading is the founder, chairman and CEO of Kading Companies S.A. Between 1979 and 1995, he held various positions at Wall Street investment banking firms. Since 1995, he has been a member of Securities Traders Association both nationally and in New York. Kading was a founder, officer, and chairman of the Board of Advanced Reconnaissance Corp. from 1997 to February 2006.

Managing director Alex M. Lemberg has worked as a business analyst on Wall Street since 1992 with the following companies: Merrill Lynch, Morgan Stanley, Barclays Capital, CIBC, Bank of America Securities, and Credit Suisse. He brings a vast understanding of the business process and the use of technologies in order to maintain a streamlined, user-friendly environment.

Accelerated Technologies Holding Corp. (ATHC), closed the day's trading session at $0.41, even for the day. The average volume for the last 60 days is 1,666 and the stock's 52-week low/high is $0.026/$1.00.

Recent News

chart

Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

Net Element, Inc. (NASDAQ: NETE) subsidiary Unified Payments is launching subscription-based payment processing services through a partnership with Payment Club, Inc. that raised $7 million to finance the latter’s expansion plans (http://nnw.fm/eLiP8). Net Element develops multi-channel electronic payment solutions, among which is Unified Payments, a flexible mobile point-of-sale system that enables small and mid-sized businesses to accept cashless payments.

Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

Net Element has also launched a new blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”

Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jeffrey Ginsburg, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed the day's trading session at $6.14, off by 1.13%, on 67,100 volume with 386 trades. The average volume for the last 60 days is 110,596 and the stock's 52-week low/high is $2.556/$33.51.

Recent News

chart

First Cobalt Corp. (TSX-V: FCC) (OTCQX: FTSSF)

The QualityStocks Daily Newsletter would like to spotlight First Cobalt Corp. (FTSSF).

First Cobalt Corp. (TSX-V: FCC; ASX: FCC; OTCQX: FTSSF) (the "Company") is pleased to announce the acquisition of 100% ownership and elimination of the outstanding royalty on the Iron Creek property in Idaho, USA.

First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF), with headquarters in Canada, is the largest land owner in the Cobalt Camp in Ontario with control of over 10,000 hectares (nearly 25,000 acres) of prospective land and 50 historic cobalt/silver mines. The company’s assets include a mill and the only permitted cobalt extraction refinery in North America capable of producing battery material, providing an integrated solution for cobalt projects. First Cobalt began drilling in the historic Cobalt Camp in 2017 and seeks to build shareholder value through new discovery and growth opportunities.

First Cobalt’s 2018 $C7 million drilling program, which includes testing different styles of mineralized areas throughout the Cobalt Camp in more than 10 past-producing mines known to contain cobalt, is a significant expansion over its 2017 exploration activities. The company received positive test drill results from the Bellellen mine location, with early results confirming the presence of high-grade cobalt and nickel, prompting First Cobalt to increase its drilling program at that site. A prospecting sampling program of existing muckpiles around the camp’s historic mines, trenches, pits and surrounding bedrock could provide an early production scenario.

First Cobalt Corp. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world’s current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

First Cobalt is embracing innovation in the mining sector, utilizing a digital compilation of 100-plus years of mining and geological data spanning the historically prolific Cobalt Mining Camp’s lifespan. First Cobalt’s management team is also assessing the ability of artificial intelligence to accelerate the discovery cycle. As a member of the Mineral Exploration Research Centre (MERC) and Metal Earth Project, First Cobalt conducts regional geophysical surveys for geological interpretation of structures controlling cobalt-silver mineralization.

The company’s clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, First Cobalt Corp. and its mining interests are primed for success.

First Cobalt Corp. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance.

First Cobalt Corp. (FTSSF), closed the day's trading session at $0.33, off by 4.18%, on 407,412 volume with 121 trades. The average volume for the last 60 days is 241,911 and the stock's 52-week low/high is $0.1983/$1.3041.

Recent News

chart

Earth Science Tech, Inc. (OTC: ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Earth Science Tech, Inc. (OTC: ETST) (“ETST" or the “Company"), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, today announces a Form 10 filing effective date, making the Company fully reporting with the Security Exchange Commission (SEC). Also today, NetworkNewsWire released a report on the company detailing how ETST is strategically positioned to be a global leader in the CBD space.

Earth Science Tech, Inc. (OTC: ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.78, off by 2.50%, on 2,112 volume with 14 trades. The average volume for the last 60 days is 11,421 and the stock's 52-week low/high is $0.324/$1.62.

Recent News

chart

ChineseInvestors.com (OTCQB: CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com, Inc. (OTCQB: CIIX), the premier financial information website for Chinese-speaking investors, today provided an update on its financial results for the fiscal year 2018 and outlook for fiscal year 2019 as the Company continues its operations in two distinct business segments: the financial services and consumer products. Also today, NetworkNewsWire released a report on the company detailing how CIIX subsidiary ChineseHempOil.com, Inc. is planning to expand its operations to more states in the U.S., as well as Vancouver and Toronto in Canada and Asian markets such as Japan, CEO Warren Wang said in an interview on MoneyTV with Donald Baillargeon (http://nnw.fm/D2Jht). It is already selling in China and Los Angeles, California.

Founded in 1999, ChineseInvestors.com (OTCQB: CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed the day's trading session at $0.54, off by 3.57%, on 198,230 volume with 134 trades. The average volume for the last 60 days is 228,646 and the stock's 52-week low/high is $0.365/$1.58.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.